Variable | AIDS-related | Non–AIDS-related | ||
---|---|---|---|---|
Unadjusted HR (95% CI) | Adjusted HR (95% CI) | Unadjusted HR (95% CI) | Adjusted HR (95% CI) | |
Sex | ||||
Female | 1.00 (−) | NS† | 1.00 (−) | NS† |
Male | 0.90 (0.47–1.71) | 0.83 (0.57–1.22) | ||
Age at first clinic visit (per 10-yr increment) | 1.23 (1.01–1.52) | 1.55 (1.22–2.22) | 1.70 (1.50–1.93) | 1.78 (1.53–2.07) |
Risk factors for acquiring HIV | ||||
Injection drug use + MSM | 1.00 (−) | 1.00 (−) | 1.00 (−) | 1.00 (−) |
Injection drug use only | 2.63 (1.25–5.52) | 2.78 (1.05–7.37) | 1.90 (1.13–3.19) | 2.73 (1.45–5.16) |
MSM only | 0.27 (0.11–0.63) | 0.30 (0.09–1.00) | 0.39 (0.23–0.66) | 0.58 (0.31–1.09) |
Other | 0.50 (0.24–1.04) | 0.51 (0.20–1.30) | 0.65 (0.41–1.04) | 0.76 (0.42–1.36) |
Unknown | 1.02 (0.39–2.67) | 0.50 (0.06–4.24) | 0.99 (0.51–1.93) | 0.94 (0.36–2.45) |
Baseline CD4 count (per increment of 100 cells/μL)‡ | 0.50 (0.42–0.59) | 0.66 (0.55–0.79) | 0.89 (0.84–0.95) | 0.90 (0.84–0.97) |
Baseline plasma viral load, log10 copies/mL‡ | 1.47 (1.23–1.75) | NS† | 1.01 (0.91–1.12) | NS† |
Visit constancy (first yr), % (as a continuous variable, per 20% increase) | 0.75 (0.61–0.93) | 0.79 (0.64–0.97) | 0.88 (0.78–0.98) | 0.90 (0.80–1.01) |
ART (ever during study period) | ||||
No | 1.00 (−) | NS† | 1.00 (−) | NS† |
Yes | 0.54 (0.28–1.08) | 0.95 (0.56–1.61) |
Note: ART = antiretroviral therapy, CI = confidence interval, HR = hazard ratio, MSM = men who have sex with men, NS = not selected.
↵* Model excludes patients whose cause of death was unknown and those who did not have 1 year of data to assess visit constancy.
↵† Variable not included in adjusted HR.
↵‡ Most recent within 6 months of first clinic visit.